Skip to main content

Table 4 Diagnostic power of platelet count to discriminate patients with HCC from patients with cirrhosis in different three staging systems

From: A novel model based on interleukin 6 and insulin-like growth factor II for detection of hepatocellular carcinoma associated with hepatitis C virus

Classification AUC Sens% Spe% PPV% NPV% AC%
Number of nodules (n, %)
 Single (67, 43.2%) 0.64 76 52 57 72 63
 Multiple (88, 56.8) 0.58 57 52 50 58 54
Macrovascular invasion (n, %)
 Absent (141, 91%) 0.61 66 52 68 49 60
 Present (14, 9%) 0.66 75 52 17 94 54
Size of nodules (n, %)
 <2 (48, 31%) 0.57 62 52 38 74 55
 >2 (107, 69%) 0.63 66 52 60 59 59
BCLC stage (n, %)
 0-A (109, 70.3%) 0.61 67 52 63 56 60
 B (46, 29.7) 0.6 62 52 38 74 55
CLIP stage (n, %)
 0-1 (122, 79%) 0.62 68 52 64 55 61
 2-3 (33, 21%) 0.6 60 52 34 76 55
Okuda stage (n, %)
 Stage I (117, 75.5%) 0.65 71 52 65 59 63
 Stage II (38, 24.5%) 0.56 55 52 37 69 53